Global Metabolomics Market By Offering (Metabolomics instruments and solutions, Services) By Technology (Capillary Electrophoresis Mass Spectrometry (CE-MS) System, Gas Chromatography–Mass Spectrometry (GC/MS) Systems, Liquid Chromatography–Mass Spectrometry (LC/MS) System, Nuclear Magnetic Resonance (NMR) Spectroscopy System, Fourier Transform Infra-Red Spectroscopy (FTIR) System) By Application (Toxicology, Functional genomics, Clinical Research/ Medical diagnostics, Agriculture, Food and Nutrition, Pharmaceutical, Biofuels, Others) By End Users (Pharmaceutical and Biopharmaceutical companies, Contract Research Organization, Research Centres, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
The study of an organism's whole metabolome is known as metabolomics, and it offers a thorough understanding of the metabolite makeup of the biological system. Numerous fields, including functional genomics, pharmaceutical and medical research and the discovery of natural products, have used metabolomics techniques, and new ones are always being investigated. Metabolomics has developed over the past few decades from a purely experimental tool to a more established and quantitative biochemical technique. Today, a number of metabolomics-based systems are used in the first stages of drug development. Metabolomics is a fast-developing area that combines techniques for identifying and quantifying cellular metabolites utilising advanced analytical technology with the use of statistical and multi-variant approaches for data extraction and interpretation. As metabolomics facilitate in identifying the ideal concentration of particular metabolites linked to the onset/progression of a disease and the exposure to or response to therapy, metabolomic investigations are gaining popularity in the life science sector. There is a growing emphasis on creative techniques that can provide effective detection and treatment of life-threatening diseases, such as cancer and CVD, due to the increased prevalence and death rate of these conditions. More study is being done in this area since metabolomics is seen as a cutting-edge strategy with great promise. Additionally, the use of metabolomic indicators has become more prevalent in medication research in recent years. Government and commercial funding for metabolomics research is rising as a result of these reasons. Thus with advancements and wide range of applications the global metabolomics market is expected to upsurge during the forecast period.
In terms of revenue, global metabolomics market was valued at US$ 2.6 Bn in 2021 growing at a CAGR of 14.8% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Metabolomics Market Revenue & Forecast, (US$ Million), 2015 – 2030
Offerings Outlook
Based on the offerings, the global metabolomics market is segmented into instruments, solutions and services. Instruments and solutions account for the highest share in the market. Factors such as technological developments in analytical instruments in terms of miniaturisation, automation, and computerization; an increase in the number of research-related activities globally in the fields of medicine, nutraceuticals are supporting the growth of metabolomics market. Furthermore, the improvement of healthcare infrastructure in developing countries for effective disease diagnosis and treatment are anticipated to drive the growth of this segment. For instance, Agilent provides a variety of dependable and cutting-edge systems for targeted metabolomics analysis, including cutting-edge software for processing, identifying, and interpreting complex metabolomics data. Agilent also has the know-how to speed up metabolomics analysis workflows at every stage, from sample preparation to data analysis. Thus with the advancements in the instruments and wide range of solutions the global metabolomics market is experiencing a huge growth.
Application Outlook
Based on the application segment, the global metabolomics market is segmented into toxicology, functional genomics, clinical research, medical diagnostics, agriculture, food and nutrition, pharmaceutical, biofuels and others. An emerging field of "omics" science called metabolomics studies the detailed characterisation of metabolites and metabolism in biological systems. A rising number of widely used biomedical applications are being produced as a result of recent developments in metabolomics technology. Metabolomics, in particular, is increasingly being utilised to diagnose illness, comprehend disease mechanisms, find new drug targets, personalise medication therapies, and track therapeutic results. Furthermore, metabolomics in food and nutrition is gaining quite popularity as it provides valuable information about the biochemical composition of foods to be rapidly obtained. The information obtained using metabolomics-based technologies is focused on improving the food quality and also aids in the identification of the link between diet and health as the biochemical profile of food heavily influences important food qualities such as flavour and shelf life. Thus, with wide range of applications the metabolomics market is expected to grow faster during the forecast period.
End Users Outlook
Based on end users’ segment, the global metabolomics market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization, research centres and others. In pharmaceutical and clinical research, metabolomics has enormous potential for new target discovery, drug mechanism of action elucidation, characterization of safety and efficacy profiles, and identification of biomarkers for early disease diagnosis, prognosis, patient stratification, and treatment response monitoring. Despite the fact that the pharmaceutical industry is only just beginning to use metabolomics, this experimental strategy has the potential to revolutionise our understanding of how drugs work by examining the drug-induced metabolic pathways linked to both drug efficacy and unfavourable drug reactions.
Region Outlook:
Based on region, North America region had the highest share in the metabolomics market in the year 2021. The key factors contributing to the metabolomics market in North America is due to the rising investment by pharmaceutical companies for drug discovery and clinical research. Additionally, the existence of significant healthcare organisations and the rising demand for metabolomics services are driving the market's growth in this area. Moreover, the presence of the leading players in North America is proving to be a beneficial factor for the growth of the metabolomics market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global metabolomics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global metabolomics market are listed below:
- Agilent Technologies, Inc.
- Bruker Corporation
- Creative Proteomics.
- Human Metabolome Technologies Inc.
- LECO Corporation
- Metabolomic Diagnostics.
- Metabolon, Inc.
- PerkinElmer Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific
- Waters Corporation.
- Other Industry Participants.
Global Metabolomics Market:
By Offering
- Metabolomics instruments and solutions
- Services
By Technology
- Capillary Electrophoresis Mass Spectrometry (CE-MS) System
- Gas Chromatography–Mass Spectrometry (GC/MS) Systems
- Liquid Chromatography–Mass Spectrometry (LC/MS) System
- Nuclear Magnetic Resonance (NMR) Spectroscopy System
- Fourier Transform Infra-Red Spectroscopy (FTIR) System
By Application
- Toxicology
- Functional genomics
- Clinical Research/ Medical diagnostics
- Agriculture
- Food and Nutrition
- Pharmaceutical
- Biofuels
- Others
By End users
- Pharmaceutical and Biopharmaceutical companies
- Contract Research Organization
- Research Centres
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Metabolomics Market
6.
Market
Synopsis: Metabolomics Market
7.
Metabolomics
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Metabolomics Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Metabolomics Market
8.
Global
Metabolomics Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Metabolomics Market Revenue (US$ Mn)
8.2. Global Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Offering
8.2.1. Metabolomics instruments and solutions
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 – 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Services
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 – 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Offering
9.
Global
Metabolomics Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Technology
9.2.1. Capillary Electrophoresis Mass Spectrometry
(CE-MS) System
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Gas Chromatography–Mass Spectrometry (GC/MS)
Systems
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Liquid Chromatography–Mass Spectrometry
(LC/MS) System
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 – 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
System
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 – 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.2.5. Fourier Transform Infra-Red Spectroscopy (FTIR)
System
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market
Forecast, 2022 – 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 – 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 – 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 – 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 – 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Technology
10. Global Metabolomics Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Application
10.2.1. Toxicology
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 – 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Functional genomics
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 – 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Clinical Research/ Medical diagnostics
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 – 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Agriculture
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 – 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Food and Nutrition
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.5.3.
Market
Forecast, 2022 – 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.2.6. Pharmaceutical
10.2.6.1.
Definition
10.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.6.3.
Market
Forecast, 2022 – 2030
10.2.6.4.
Compound
Annual Growth Rate (CAGR)
10.2.6.5.
Regional
Bifurcation
10.2.6.5.1.
North
America
10.2.6.5.1.1. Market Estimation, 2015 - 2021
10.2.6.5.1.2. Market Forecast, 2022 – 2030
10.2.6.5.2.
Europe
10.2.6.5.2.1. Market Estimation, 2015 - 2021
10.2.6.5.2.2. Market Forecast, 2022 – 2030
10.2.6.5.3.
Asia
Pacific
10.2.6.5.3.1. Market Estimation, 2015 - 2021
10.2.6.5.3.2. Market Forecast, 2022 – 2030
10.2.6.5.4.
Middle
East and Africa
10.2.6.5.4.1. Market Estimation, 2015 - 2021
10.2.6.5.4.2. Market Forecast, 2022 – 2030
10.2.6.5.5.
Latin
America
10.2.6.5.5.1. Market Estimation, 2015 - 2021
10.2.6.5.5.2. Market Forecast, 2022 – 2030
10.2.7. Biofuels
10.2.7.1.
Definition
10.2.7.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.7.3.
Market
Forecast, 2022 – 2030
10.2.7.4.
Compound
Annual Growth Rate (CAGR)
10.2.7.5.
Regional
Bifurcation
10.2.7.5.1.
North
America
10.2.7.5.1.1. Market Estimation, 2015 - 2021
10.2.7.5.1.2. Market Forecast, 2022 – 2030
10.2.7.5.2.
Europe
10.2.7.5.2.1. Market Estimation, 2015 - 2021
10.2.7.5.2.2. Market Forecast, 2022 – 2030
10.2.7.5.3.
Asia
Pacific
10.2.7.5.3.1. Market Estimation, 2015 - 2021
10.2.7.5.3.2. Market Forecast, 2022 – 2030
10.2.7.5.4.
Middle
East and Africa
10.2.7.5.4.1. Market Estimation, 2015 - 2021
10.2.7.5.4.2. Market Forecast, 2022 – 2030
10.2.7.5.5.
Latin
America
10.2.7.5.5.1. Market Estimation, 2015 - 2021
10.2.7.5.5.2. Market Forecast, 2022 – 2030
10.2.8. Others
10.2.8.1.
Definition
10.2.8.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.8.3.
Market
Forecast, 2022 – 2030
10.2.8.4.
Compound
Annual Growth Rate (CAGR)
10.2.8.5.
Regional
Bifurcation
10.2.8.5.1.
North
America
10.2.8.5.1.1. Market Estimation, 2015 - 2021
10.2.8.5.1.2. Market Forecast, 2022 – 2030
10.2.8.5.2.
Europe
10.2.8.5.2.1. Market Estimation, 2015 - 2021
10.2.8.5.2.2. Market Forecast, 2022 – 2030
10.2.8.5.3.
Asia
Pacific
10.2.8.5.3.1. Market Estimation, 2015 - 2021
10.2.8.5.3.2. Market Forecast, 2022 – 2030
10.2.8.5.4.
Middle
East and Africa
10.2.8.5.4.1. Market Estimation, 2015 - 2021
10.2.8.5.4.2. Market Forecast, 2022 – 2030
10.2.8.5.5.
Latin
America
10.2.8.5.5.1. Market Estimation, 2015 - 2021
10.2.8.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Metabolomics Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Metabolomics Market Revenue (US$ Mn)
and Forecasts, By End users
11.2.1. Pharmaceutical and Biopharmaceutical
companies
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 – 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Contract Research Organization
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 – 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Research Centres
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 – 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Others
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 – 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End users
12. North America Metabolomics Market Analysis
and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Metabolomics Market Revenue
(US$ Mn)
12.2. North America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Offering
12.2.1. Metabolomics instruments and solutions
12.2.2. Services
12.3. North America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Technology
12.3.1. Capillary Electrophoresis Mass Spectrometry
(CE-MS) System
12.3.2. Gas Chromatography–Mass Spectrometry (GC/MS)
Systems
12.3.3. Liquid Chromatography–Mass Spectrometry
(LC/MS) System
12.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
System
12.3.5. Fourier Transform Infra-Red Spectroscopy
(FTIR) System
12.4. North America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Application
12.4.1. Toxicology
12.4.2. Functional genomics
12.4.3. Clinical Research/ Medical diagnostics
12.4.4. Agriculture
12.4.5. Food and Nutrition
12.4.6. Pharmaceutical
12.4.7. Biofuels
12.4.8. Others
12.5. North America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By End users
12.5.1. Pharmaceutical and Biopharmaceutical
companies
12.5.2. Contract Research Organization
12.5.3. Research Centres
12.5.4. Others
12.6. North America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.1.1.1.
Metabolomics
instruments and solutions
12.6.1.1.2.
Services
12.6.1.2.
U.S
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.1.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
12.6.1.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
12.6.1.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
12.6.1.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
12.6.1.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
12.6.1.3.
U.S
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.3.1.
Toxicology
12.6.1.3.2.
Functional
genomics
12.6.1.3.3.
Clinical
Research/ Medical diagnostics
12.6.1.3.4.
Agriculture
12.6.1.3.5.
Food and
Nutrition
12.6.1.3.6.
Pharmaceutical
12.6.1.3.7.
Biofuels
12.6.1.3.8.
Others
12.6.1.4.
U.S
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
12.6.1.4.1.
Pharmaceutical
and Biopharmaceutical companies
12.6.1.4.2.
Contract
Research Organization
12.6.1.4.3.
Research
Centres
12.6.1.4.4.
Others
12.6.2. Canada
12.6.2.1.
Canada
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.2.1.1.
Metabolomics
instruments and solutions
12.6.2.1.2.
Services
12.6.2.2.
Canada
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.2.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
12.6.2.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
12.6.2.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
12.6.2.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
12.6.2.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
12.6.2.3.
Canada
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.3.1.
Toxicology
12.6.2.3.2.
Functional
genomics
12.6.2.3.3.
Clinical
Research/ Medical diagnostics
12.6.2.3.4.
Agriculture
12.6.2.3.5.
Food and
Nutrition
12.6.2.3.6.
Pharmaceutical
12.6.2.3.7.
Biofuels
12.6.2.3.8.
Others
12.6.2.4.
Canada
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
12.6.2.4.1.
Pharmaceutical
and Biopharmaceutical companies
12.6.2.4.2.
Contract
Research Organization
12.6.2.4.3.
Research
Centres
12.6.2.4.4.
Others
12.6.3. Mexico
12.6.3.1.
Mexico
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.3.1.1.
Metabolomics
instruments and solutions
12.6.3.1.2.
Services
12.6.3.2.
Mexico
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.3.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
12.6.3.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
12.6.3.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
12.6.3.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
12.6.3.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
12.6.3.3.
Mexico
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.3.1.
Toxicology
12.6.3.3.2.
Functional
genomics
12.6.3.3.3.
Clinical
Research/ Medical diagnostics
12.6.3.3.4.
Agriculture
12.6.3.3.5.
Food and
Nutrition
12.6.3.3.6.
Pharmaceutical
12.6.3.3.7.
Biofuels
12.6.3.3.8.
Others
12.6.3.4.
Mexico
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
12.6.3.4.1.
Pharmaceutical
and Biopharmaceutical companies
12.6.3.4.2.
Contract
Research Organization
12.6.3.4.3.
Research
Centres
12.6.3.4.4.
Others
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.4.1.1.
Metabolomics
instruments and solutions
12.6.4.1.2.
Services
12.6.4.2.
Rest of
North America Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.4.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
12.6.4.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
12.6.4.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
12.6.4.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
12.6.4.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
12.6.4.3.
Rest of
North America Metabolomics Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.4.3.1.
Toxicology
12.6.4.3.2.
Functional
genomics
12.6.4.3.3.
Clinical
Research/ Medical diagnostics
12.6.4.3.4.
Agriculture
12.6.4.3.5.
Food and
Nutrition
12.6.4.3.6.
Pharmaceutical
12.6.4.3.7.
Biofuels
12.6.4.3.8.
Others
12.6.4.4.
Rest of
North America Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
12.6.4.4.1.
Pharmaceutical
and Biopharmaceutical companies
12.6.4.4.2.
Contract
Research Organization
12.6.4.4.3.
Research
Centres
12.6.4.4.4.
Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Offering
12.7.3. By Technology
12.7.4. By Application
12.7.5. By End users
13. Europe Metabolomics Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Metabolomics Market Revenue (US$ Mn)
13.2. Europe Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Offering
13.2.1. Metabolomics instruments and solutions
13.2.2. Services
13.3. Europe Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Technology
13.3.1. Capillary Electrophoresis Mass Spectrometry
(CE-MS) System
13.3.2. Gas Chromatography–Mass Spectrometry (GC/MS)
Systems
13.3.3. Liquid Chromatography–Mass Spectrometry
(LC/MS) System
13.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
System
13.3.5. Fourier Transform Infra-Red Spectroscopy
(FTIR) System
13.4. Europe Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Application
13.4.1. Toxicology
13.4.2. Functional genomics
13.4.3. Clinical Research/ Medical diagnostics
13.4.4. Agriculture
13.4.5. Food and Nutrition
13.4.6. Pharmaceutical
13.4.7. Biofuels
13.4.8. Others
13.5. Europe Metabolomics Market Revenue (US$ Mn)
and Forecasts, By End users
13.5.1. Pharmaceutical and Biopharmaceutical
companies
13.5.2. Contract Research Organization
13.5.3. Research Centres
13.5.4. Others
13.6. Europe Metabolomics Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.1. France
13.6.1.1.
France
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.1.1.1.
Metabolomics
instruments and solutions
13.6.1.1.2.
Services
13.6.1.2.
France
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.1.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.1.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.1.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.1.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.1.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.1.3.
France
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1.
Toxicology
13.6.1.3.2.
Functional
genomics
13.6.1.3.3.
Clinical
Research/ Medical diagnostics
13.6.1.3.4.
Agriculture
13.6.1.3.5.
Food and
Nutrition
13.6.1.3.6.
Pharmaceutical
13.6.1.3.7.
Biofuels
13.6.1.3.8.
Others
13.6.1.4.
France
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.1.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.1.4.2.
Contract
Research Organization
13.6.1.4.3.
Research
Centres
13.6.1.4.4.
Others
13.6.2. The UK
13.6.2.1.
The UK
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.2.1.1.
Metabolomics
instruments and solutions
13.6.2.1.2.
Services
13.6.2.2.
The UK
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.2.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.2.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.2.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.2.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.2.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.2.3.
The UK
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.3.1.
Toxicology
13.6.2.3.2.
Functional
genomics
13.6.2.3.3.
Clinical
Research/ Medical diagnostics
13.6.2.3.4.
Agriculture
13.6.2.3.5.
Food and
Nutrition
13.6.2.3.6.
Pharmaceutical
13.6.2.3.7.
Biofuels
13.6.2.3.8.
Others
13.6.2.4.
The UK
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.2.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.2.4.2.
Contract
Research Organization
13.6.2.4.3.
Research
Centres
13.6.2.4.4.
Others
13.6.3. Spain
13.6.3.1.
Spain
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.3.1.1.
Metabolomics
instruments and solutions
13.6.3.1.2.
Services
13.6.3.2.
Spain
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.3.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.3.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.3.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.3.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.3.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.3.3.
Spain
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.3.1.
Toxicology
13.6.3.3.2.
Functional
genomics
13.6.3.3.3.
Clinical
Research/ Medical diagnostics
13.6.3.3.4.
Agriculture
13.6.3.3.5.
Food and
Nutrition
13.6.3.3.6.
Pharmaceutical
13.6.3.3.7.
Biofuels
13.6.3.3.8.
Others
13.6.3.4.
Spain
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.3.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.3.4.2.
Contract
Research Organization
13.6.3.4.3.
Research
Centres
13.6.3.4.4.
Others
13.6.4. Germany
13.6.4.1.
Germany
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.4.1.1.
Metabolomics
instruments and solutions
13.6.4.1.2.
Services
13.6.4.2.
Germany
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.4.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.4.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.4.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.4.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.4.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.4.3.
Germany
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.3.1.
Toxicology
13.6.4.3.2.
Functional
genomics
13.6.4.3.3.
Clinical
Research/ Medical diagnostics
13.6.4.3.4.
Agriculture
13.6.4.3.5.
Food and
Nutrition
13.6.4.3.6.
Pharmaceutical
13.6.4.3.7.
Biofuels
13.6.4.3.8.
Others
13.6.4.4.
Germany
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.4.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.4.4.2.
Contract
Research Organization
13.6.4.4.3.
Research
Centres
13.6.4.4.4.
Others
13.6.5. Italy
13.6.5.1.
Italy
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.5.1.1.
Metabolomics
instruments and solutions
13.6.5.1.2.
Services
13.6.5.2.
Italy
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.5.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.5.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.5.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.5.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.5.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.5.3.
Italy
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.3.1.
Toxicology
13.6.5.3.2.
Functional
genomics
13.6.5.3.3.
Clinical
Research/ Medical diagnostics
13.6.5.3.4.
Agriculture
13.6.5.3.5.
Food and
Nutrition
13.6.5.3.6.
Pharmaceutical
13.6.5.3.7.
Biofuels
13.6.5.3.8.
Others
13.6.5.4.
Italy
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.5.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.5.4.2.
Contract
Research Organization
13.6.5.4.3.
Research
Centres
13.6.5.4.4.
Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.6.1.1.
Metabolomics
instruments and solutions
13.6.6.1.2.
Services
13.6.6.2.
Nordic
Countries Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.6.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.6.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.6.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.6.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.6.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.6.3.
Nordic
Countries Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1.
Toxicology
13.6.6.3.2.
Functional
genomics
13.6.6.3.3.
Clinical
Research/ Medical diagnostics
13.6.6.3.4.
Agriculture
13.6.6.3.5.
Food and
Nutrition
13.6.6.3.6.
Pharmaceutical
13.6.6.3.7.
Biofuels
13.6.6.3.8.
Others
13.6.6.4.
Nordic
Countries Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.6.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.6.4.2.
Contract
Research Organization
13.6.6.4.3.
Research
Centres
13.6.6.4.4.
Others
13.6.6.5.
Nordic
Countries Metabolomics Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.7.1.1.
Metabolomics
instruments and solutions
13.6.7.1.2.
Services
13.6.7.2.
Benelux
Union Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.7.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.7.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.7.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.7.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.7.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.7.3.
Benelux
Union Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1.
Toxicology
13.6.7.3.2.
Functional
genomics
13.6.7.3.3.
Clinical
Research/ Medical diagnostics
13.6.7.3.4.
Agriculture
13.6.7.3.5.
Food and
Nutrition
13.6.7.3.6.
Pharmaceutical
13.6.7.3.7.
Biofuels
13.6.7.3.8.
Others
13.6.7.4.
Benelux
Union Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.7.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.7.4.2.
Contract
Research Organization
13.6.7.4.3.
Research
Centres
13.6.7.4.4.
Others
13.6.7.5.
Benelux
Union Metabolomics Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.8.1.1.
Metabolomics
instruments and solutions
13.6.8.1.2.
Services
13.6.8.2.
Rest of
Europe Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.8.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
13.6.8.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
13.6.8.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
13.6.8.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
13.6.8.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
13.6.8.3.
Rest of
Europe Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1.
Toxicology
13.6.8.3.2.
Functional
genomics
13.6.8.3.3.
Clinical
Research/ Medical diagnostics
13.6.8.3.4.
Agriculture
13.6.8.3.5.
Food and
Nutrition
13.6.8.3.6.
Pharmaceutical
13.6.8.3.7.
Biofuels
13.6.8.3.8.
Others
13.6.8.4.
Rest of
Europe Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
13.6.8.4.1.
Pharmaceutical
and Biopharmaceutical companies
13.6.8.4.2.
Contract
Research Organization
13.6.8.4.3.
Research
Centres
13.6.8.4.4.
Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Offering
13.7.3. By Technology
13.7.4. By Application
13.7.5. By End users
14. Asia Pacific Metabolomics Market Analysis
and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Metabolomics Market Revenue (US$
Mn)
14.2. Asia Pacific Metabolomics Market Revenue (US$
Mn) and Forecasts, By Offering
14.2.1. Metabolomics instruments and solutions
14.2.2. Services
14.3. Asia Pacific Metabolomics Market Revenue (US$
Mn) and Forecasts, By Technology
14.3.1. Capillary Electrophoresis Mass Spectrometry
(CE-MS) System
14.3.2. Gas Chromatography–Mass Spectrometry (GC/MS)
Systems
14.3.3. Liquid Chromatography–Mass Spectrometry
(LC/MS) System
14.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
System
14.3.5. Fourier Transform Infra-Red Spectroscopy
(FTIR) System
14.4. Asia Pacific Metabolomics Market Revenue (US$
Mn) and Forecasts, By Application
14.4.1. Toxicology
14.4.2. Functional genomics
14.4.3. Clinical Research/ Medical diagnostics
14.4.4. Agriculture
14.4.5. Food and Nutrition
14.4.6. Pharmaceutical
14.4.7. Biofuels
14.4.8. Others
14.5. Asia Pacific Metabolomics Market Revenue (US$
Mn) and Forecasts, By End users
14.5.1. Pharmaceutical and Biopharmaceutical
companies
14.5.2. Contract Research Organization
14.5.3. Research Centres
14.5.4. Others
14.6. Asia Pacific Metabolomics Market Revenue (US$
Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1.
China
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.1.1.1.
Metabolomics
instruments and solutions
14.6.1.1.2.
Services
14.6.1.2.
China
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.1.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.1.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.1.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.1.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.1.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.1.3.
China
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.3.1.
Toxicology
14.6.1.3.2.
Functional
genomics
14.6.1.3.3.
Clinical
Research/ Medical diagnostics
14.6.1.3.4.
Agriculture
14.6.1.3.5.
Food and
Nutrition
14.6.1.3.6.
Pharmaceutical
14.6.1.3.7.
Biofuels
14.6.1.3.8.
Others
14.6.1.4.
China
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.1.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.1.4.2.
Contract
Research Organization
14.6.1.4.3.
Research
Centres
14.6.1.4.4.
Others
14.6.2. Japan
14.6.2.1.
Japan
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.2.1.1.
Metabolomics
instruments and solutions
14.6.2.1.2.
Services
14.6.2.2.
Japan
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.2.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.2.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.2.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.2.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.2.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.2.3.
Japan
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.3.1.
Toxicology
14.6.2.3.2.
Functional
genomics
14.6.2.3.3.
Clinical
Research/ Medical diagnostics
14.6.2.3.4.
Agriculture
14.6.2.3.5.
Food and
Nutrition
14.6.2.3.6.
Pharmaceutical
14.6.2.3.7.
Biofuels
14.6.2.3.8.
Others
14.6.2.4.
Japan
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.2.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.2.4.2.
Contract
Research Organization
14.6.2.4.3.
Research
Centres
14.6.2.4.4.
Others
14.6.3. India
14.6.3.1.
India
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.3.1.1.
Metabolomics
instruments and solutions
14.6.3.1.2.
Services
14.6.3.2.
India
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.3.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.3.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.3.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.3.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.3.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.3.3.
India
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.3.1.
Toxicology
14.6.3.3.2.
Functional
genomics
14.6.3.3.3.
Clinical
Research/ Medical diagnostics
14.6.3.3.4.
Agriculture
14.6.3.3.5.
Food and
Nutrition
14.6.3.3.6.
Pharmaceutical
14.6.3.3.7.
Biofuels
14.6.3.3.8.
Others
14.6.3.4.
India
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.3.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.3.4.2.
Contract
Research Organization
14.6.3.4.3.
Research
Centres
14.6.3.4.4.
Others
14.6.4. New Zealand
14.6.4.1.
New
Zealand Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.4.1.1.
Metabolomics
instruments and solutions
14.6.4.1.2.
Services
14.6.4.2.
New
Zealand Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.4.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.4.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.4.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.4.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.4.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.4.3.
New
Zealand Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.3.1.
Toxicology
14.6.4.3.2.
Functional
genomics
14.6.4.3.3.
Clinical
Research/ Medical diagnostics
14.6.4.3.4.
Agriculture
14.6.4.3.5.
Food and
Nutrition
14.6.4.3.6.
Pharmaceutical
14.6.4.3.7.
Biofuels
14.6.4.3.8.
Others
14.6.4.4.
New
Zealand Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.4.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.4.4.2.
Contract
Research Organization
14.6.4.4.3.
Research
Centres
14.6.4.4.4.
Others
14.6.5. Australia
14.6.5.1.
Australia
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.5.1.1.
Metabolomics
instruments and solutions
14.6.5.1.2.
Services
14.6.5.2.
Australia
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.5.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.5.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.5.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.5.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.5.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.5.3.
Australia
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.3.1.
Toxicology
14.6.5.3.2.
Functional
genomics
14.6.5.3.3.
Clinical
Research/ Medical diagnostics
14.6.5.3.4.
Agriculture
14.6.5.3.5.
Food and
Nutrition
14.6.5.3.6.
Pharmaceutical
14.6.5.3.7.
Biofuels
14.6.5.3.8.
Others
14.6.5.4.
Australia
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.5.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.5.4.2.
Contract
Research Organization
14.6.5.4.3.
Research
Centres
14.6.5.4.4.
Others
14.6.6. South Korea
14.6.6.1.
South
Korea Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.6.1.1.
Metabolomics
instruments and solutions
14.6.6.1.2.
Services
14.6.6.2.
South
Korea Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.6.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.6.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.6.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.6.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.6.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.6.3.
South
Korea Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.3.1.
Toxicology
14.6.6.3.2.
Functional
genomics
14.6.6.3.3.
Clinical
Research/ Medical diagnostics
14.6.6.3.4.
Agriculture
14.6.6.3.5.
Food and
Nutrition
14.6.6.3.6.
Pharmaceutical
14.6.6.3.7.
Biofuels
14.6.6.3.8.
Others
14.6.6.4.
South
Korea Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.6.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.6.4.2.
Contract
Research Organization
14.6.6.4.3.
Research
Centres
14.6.6.4.4.
Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.7.1.1.
Metabolomics
instruments and solutions
14.6.7.1.2.
Services
14.6.7.2.
Southeast
Asia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.7.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.7.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.7.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.7.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.7.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.7.3.
Southeast
Asia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1.
Toxicology
14.6.7.3.2.
Functional
genomics
14.6.7.3.3.
Clinical
Research/ Medical diagnostics
14.6.7.3.4.
Agriculture
14.6.7.3.5.
Food and
Nutrition
14.6.7.3.6.
Pharmaceutical
14.6.7.3.7.
Biofuels
14.6.7.3.8.
Others
14.6.7.4.
Southeast
Asia Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.7.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.7.4.2.
Contract
Research Organization
14.6.7.4.3.
Research
Centres
14.6.7.4.4.
Others
14.6.7.5.
Southeast
Asia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.8.1.1.
Metabolomics
instruments and solutions
14.6.8.1.2.
Services
14.6.8.2.
Rest of
Asia Pacific Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.8.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
14.6.8.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
14.6.8.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
14.6.8.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
14.6.8.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
14.6.8.3.
Rest of
Asia Pacific Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1.
Toxicology
14.6.8.3.2.
Functional
genomics
14.6.8.3.3.
Clinical
Research/ Medical diagnostics
14.6.8.3.4.
Agriculture
14.6.8.3.5.
Food and
Nutrition
14.6.8.3.6.
Pharmaceutical
14.6.8.3.7.
Biofuels
14.6.8.3.8.
Others
14.6.8.4.
Rest of
Asia Pacific Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
14.6.8.4.1.
Pharmaceutical
and Biopharmaceutical companies
14.6.8.4.2.
Contract
Research Organization
14.6.8.4.3.
Research
Centres
14.6.8.4.4.
Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Offering
14.7.3. By Technology
14.7.4. By Application
14.7.5. By End users
15. Middle East and Africa Metabolomics Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Metabolomics Market
Revenue (US$ Mn)
15.2. Middle East and Africa Metabolomics Market
Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Metabolomics instruments and solutions
15.2.2. Services
15.3. Middle East and Africa Metabolomics Market
Revenue (US$ Mn) and Forecasts, By Technology
15.3.1. Capillary Electrophoresis Mass Spectrometry
(CE-MS) System
15.3.2. Gas Chromatography–Mass Spectrometry (GC/MS)
Systems
15.3.3. Liquid Chromatography–Mass Spectrometry
(LC/MS) System
15.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
System
15.3.5. Fourier Transform Infra-Red Spectroscopy
(FTIR) System
15.4. Middle East and Africa Metabolomics Market
Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Toxicology
15.4.2. Functional genomics
15.4.3. Clinical Research/ Medical diagnostics
15.4.4. Agriculture
15.4.5. Food and Nutrition
15.4.6. Pharmaceutical
15.4.7. Biofuels
15.4.8. Others
15.5. Middle East and Africa Metabolomics Market
Revenue (US$ Mn) and Forecasts, By End users
15.5.1. Pharmaceutical and Biopharmaceutical
companies
15.5.2. Contract Research Organization
15.5.3. Research Centres
15.5.4. Others
15.6. Middle East and Africa Metabolomics Market
Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.1.1.1.
Metabolomics
instruments and solutions
15.6.1.1.2.
Services
15.6.1.2.
Saudi
Arabia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.1.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
15.6.1.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
15.6.1.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
15.6.1.2.4.
Nuclear Magnetic
Resonance (NMR) Spectroscopy System
15.6.1.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
15.6.1.3.
Saudi
Arabia Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.3.1.
Toxicology
15.6.1.3.2.
Functional
genomics
15.6.1.3.3.
Clinical
Research/ Medical diagnostics
15.6.1.3.4.
Agriculture
15.6.1.3.5.
Food and
Nutrition
15.6.1.3.6.
Pharmaceutical
15.6.1.3.7.
Biofuels
15.6.1.3.8.
Others
15.6.1.4.
Saudi
Arabia Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
15.6.1.4.1.
Pharmaceutical
and Biopharmaceutical companies
15.6.1.4.2.
Contract
Research Organization
15.6.1.4.3.
Research
Centres
15.6.1.4.4.
Others
15.6.2. UAE
15.6.2.1.
UAE
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.2.1.1.
Metabolomics
instruments and solutions
15.6.2.1.2.
Services
15.6.2.2.
UAE
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.2.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
15.6.2.2.2.
Gas Chromatography–Mass
Spectrometry (GC/MS) Systems
15.6.2.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
15.6.2.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
15.6.2.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
15.6.2.3.
UAE
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.3.1.
Toxicology
15.6.2.3.2.
Functional
genomics
15.6.2.3.3.
Clinical
Research/ Medical diagnostics
15.6.2.3.4.
Agriculture
15.6.2.3.5.
Food and
Nutrition
15.6.2.3.6.
Pharmaceutical
15.6.2.3.7.
Biofuels
15.6.2.3.8.
Others
15.6.2.4.
UAE
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
15.6.2.4.1.
Pharmaceutical
and Biopharmaceutical companies
15.6.2.4.2.
Contract
Research Organization
15.6.2.4.3.
Research
Centres
15.6.2.4.4.
Others
15.6.3. Egypt
15.6.3.1.
Egypt
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.3.1.1.
Metabolomics
instruments and solutions
15.6.3.1.2.
Services
15.6.3.2.
Egypt
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.3.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
15.6.3.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
15.6.3.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
15.6.3.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
15.6.3.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
15.6.3.3.
Egypt
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.3.1.
Toxicology
15.6.3.3.2.
Functional
genomics
15.6.3.3.3.
Clinical
Research/ Medical diagnostics
15.6.3.3.4.
Agriculture
15.6.3.3.5.
Food and
Nutrition
15.6.3.3.6.
Pharmaceutical
15.6.3.3.7.
Biofuels
15.6.3.3.8.
Others
15.6.3.4.
Egypt
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
15.6.3.4.1.
Pharmaceutical
and Biopharmaceutical companies
15.6.3.4.2.
Contract
Research Organization
15.6.3.4.3.
Research
Centres
15.6.3.4.4.
Others
15.6.4. Kuwait
15.6.4.1.
Kuwait
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.4.1.1.
Metabolomics
instruments and solutions
15.6.4.1.2.
Services
15.6.4.2.
Kuwait
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.4.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
15.6.4.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
15.6.4.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
15.6.4.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
15.6.4.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
15.6.4.3.
Kuwait
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.3.1.
Toxicology
15.6.4.3.2.
Functional
genomics
15.6.4.3.3.
Clinical
Research/ Medical diagnostics
15.6.4.3.4.
Agriculture
15.6.4.3.5.
Food and
Nutrition
15.6.4.3.6.
Pharmaceutical
15.6.4.3.7.
Biofuels
15.6.4.3.8.
Others
15.6.4.4.
Kuwait
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
15.6.4.4.1.
Pharmaceutical
and Biopharmaceutical companies
15.6.4.4.2.
Contract
Research Organization
15.6.4.4.3.
Research
Centres
15.6.4.4.4.
Others
15.6.5. South Africa
15.6.5.1.
South
Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.5.1.1.
Metabolomics
instruments and solutions
15.6.5.1.2.
Services
15.6.5.2.
South
Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.5.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
15.6.5.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
15.6.5.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
15.6.5.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
15.6.5.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
15.6.5.3.
South
Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.3.1.
Toxicology
15.6.5.3.2.
Functional
genomics
15.6.5.3.3.
Clinical
Research/ Medical diagnostics
15.6.5.3.4.
Agriculture
15.6.5.3.5.
Food and
Nutrition
15.6.5.3.6.
Pharmaceutical
15.6.5.3.7.
Biofuels
15.6.5.3.8.
Others
15.6.5.4.
South
Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
15.6.5.4.1.
Pharmaceutical
and Biopharmaceutical companies
15.6.5.4.2.
Contract
Research Organization
15.6.5.4.3.
Research
Centres
15.6.5.4.4.
Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.6.1.1.
Metabolomics
instruments and solutions
15.6.6.1.2.
Services
15.6.6.2.
Rest of
Middle East & Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By
Technology
15.6.6.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
15.6.6.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
15.6.6.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
15.6.6.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
15.6.6.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
15.6.6.3.
Rest of
Middle East & Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.6.3.1.
Toxicology
15.6.6.3.2.
Functional
genomics
15.6.6.3.3.
Clinical
Research/ Medical diagnostics
15.6.6.3.4.
Agriculture
15.6.6.3.5.
Food and
Nutrition
15.6.6.3.6.
Pharmaceutical
15.6.6.3.7.
Biofuels
15.6.6.3.8.
Others
15.6.6.4.
Rest of
Middle East & Africa Metabolomics Market Revenue (US$ Mn) and Forecasts, By
End users
15.6.6.4.1.
Pharmaceutical
and Biopharmaceutical companies
15.6.6.4.2.
Contract
Research Organization
15.6.6.4.3.
Research
Centres
15.6.6.4.4.
Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Offering
15.7.3. By Technology
15.7.4. By Application
15.7.5. By End users
16. Latin America Metabolomics Market Analysis
and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Metabolomics Market Revenue
(US$ Mn)
16.2. Latin America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Offering
16.2.1. Metabolomics instruments and solutions
16.2.2. Services
16.3. Latin America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Technology
16.3.1. Capillary Electrophoresis Mass Spectrometry
(CE-MS) System
16.3.2. Gas Chromatography–Mass Spectrometry (GC/MS)
Systems
16.3.3. Liquid Chromatography–Mass Spectrometry
(LC/MS) System
16.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
System
16.3.5. Fourier Transform Infra-Red Spectroscopy
(FTIR) System
16.4. Latin America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Application
16.4.1. Toxicology
16.4.2. Functional genomics
16.4.3. Clinical Research/ Medical diagnostics
16.4.4. Agriculture
16.4.5. Food and Nutrition
16.4.6. Pharmaceutical
16.4.7. Biofuels
16.4.8. Others
16.5. Latin America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By End users
16.5.1. Pharmaceutical and Biopharmaceutical
companies
16.5.2. Contract Research Organization
16.5.3. Research Centres
16.5.4. Others
16.6. Latin America Metabolomics Market Revenue
(US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.1.1.1.
Metabolomics
instruments and solutions
16.6.1.1.2.
Services
16.6.1.2.
Brazil
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.1.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
16.6.1.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
16.6.1.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
16.6.1.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
16.6.1.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
16.6.1.3.
Brazil
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.3.1.
Toxicology
16.6.1.3.2.
Functional
genomics
16.6.1.3.3.
Clinical
Research/ Medical diagnostics
16.6.1.3.4.
Agriculture
16.6.1.3.5.
Food and
Nutrition
16.6.1.3.6.
Pharmaceutical
16.6.1.3.7.
Biofuels
16.6.1.3.8.
Others
16.6.1.4.
Brazil
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
16.6.1.4.1.
Pharmaceutical
and Biopharmaceutical companies
16.6.1.4.2.
Contract
Research Organization
16.6.1.4.3.
Research
Centres
16.6.1.4.4.
Others
16.6.2. Argentina
16.6.2.1.
Argentina
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.2.1.1.
Metabolomics
instruments and solutions
16.6.2.1.2.
Services
16.6.2.2.
Argentina
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.2.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
16.6.2.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
16.6.2.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
16.6.2.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
16.6.2.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
16.6.2.3.
Argentina
Metabolomics Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.3.1.
Toxicology
16.6.2.3.2.
Functional
genomics
16.6.2.3.3.
Clinical
Research/ Medical diagnostics
16.6.2.3.4.
Agriculture
16.6.2.3.5.
Food and
Nutrition
16.6.2.3.6.
Pharmaceutical
16.6.2.3.7.
Biofuels
16.6.2.3.8.
Others
16.6.2.4.
Argentina
Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
16.6.2.4.1.
Pharmaceutical
and Biopharmaceutical companies
16.6.2.4.2.
Contract
Research Organization
16.6.2.4.3.
Research
Centres
16.6.2.4.4.
Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America Metabolomics Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.3.1.1.
Metabolomics
instruments and solutions
16.6.3.1.2.
Services
16.6.3.2.
Rest of
Latin America Metabolomics Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.3.2.1.
Capillary
Electrophoresis Mass Spectrometry (CE-MS) System
16.6.3.2.2.
Gas
Chromatography–Mass Spectrometry (GC/MS) Systems
16.6.3.2.3.
Liquid
Chromatography–Mass Spectrometry (LC/MS) System
16.6.3.2.4.
Nuclear
Magnetic Resonance (NMR) Spectroscopy System
16.6.3.2.5.
Fourier
Transform Infra-Red Spectroscopy (FTIR) System
16.6.3.3.
Rest of
Latin America Metabolomics Market Revenue (US$ Mn) and Forecasts, By
Application
16.6.3.3.1.
Toxicology
16.6.3.3.2.
Functional
genomics
16.6.3.3.3.
Clinical
Research/ Medical diagnostics
16.6.3.3.4.
Agriculture
16.6.3.3.5.
Food and
Nutrition
16.6.3.3.6.
Pharmaceutical
16.6.3.3.7.
Biofuels
16.6.3.3.8.
Others
16.6.3.4.
Rest of
Latin America Metabolomics Market Revenue (US$ Mn) and Forecasts, By End users
16.6.3.4.1.
Pharmaceutical
and Biopharmaceutical companies
16.6.3.4.2.
Contract
Research Organization
16.6.3.4.3.
Research
Centres
16.6.3.4.4.
Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Offering
16.7.3. By Technology
16.7.4. By Application
16.7.5. By End users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Agilent Technologies, Inc.
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Bruker Corporation
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Creative Proteomics.
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Human Metabolome Technologies Inc.,
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. LECO Corporation
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Metabolomic Diagnostics.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Metabolon, Inc.
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Shimadzu Corporation
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Thermo Fisher Scientific
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Waters Corporation
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Other Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.